PLA2R1 and nephrotic syndrome: As shown in Table 2, eight studies published between 2018 and 2024 that evaluated the diagnostic accuracy of serum anti-PLA2R antibodies for diagnosing MN in patients with nephrotic syndrome were included in this systematic review [10-17].